ICP-488 not checked
Beijing InnoCare Pharma Tech Co., Ltd.
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Eligible patients will receive ICP-488 Placebo orally as per the protocol”In the company’s words, NCT06842199 on ClinicalTrials.gov
- Tested for
- Plaque Psoriasis Patients, Cutaneous Lupus Erythematosus (CLE), Primary Sjögren's Syndrome
- Main trialPhase 3
- “This is a multicenter, randomized, double-blind, placebo-controlled Phase III clinical study to evaluate the efficacy, safety, PK characteristics of ICP-488 in Chinese adults with moderate to severe plaque psoriasis.”In the company’s words, NCT06842199 on ClinicalTrials.gov
Other drugs for Cutaneous Lupus Erythematosus (CLE)
- EnpatoranEMD Serono Research & Development Institute, Inc. · Phase 3
- LitifilimabBiogen · Phase 3
- AfimetoranBeeline Medicines Corporation · Bristol Myers Squibb · Phase 2/3
- AnifrolumabAstraZeneca · Phase 3
- VENT-03Ventus Therapeutics U.S., Inc. · Phase 2
- DB-2304DualityBio Inc. · Phase 1/2
Coming up2
- Mar 2027Phase 2 trial completes · ClinicalTrials.gov
- Dec 2028Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials5
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | May 2026 | Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis | |
| Phase 2Recruiting | Mar 2027 | Evaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind Study | |
| Phase 2Not yet recruiting | Dec 2028 | A Study to Evaluate the Efficacy and Safety of ICP-488 in Participants With Primary Sjögren's Syndrome | |
| Phase 2Completed | 5 Aug 2024 | Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis | |
| Phase 1Unknown | 30 Oct 2023 | A Clinical Study of ICP-488 in Healthy Subjects and Patients With Psoriasis |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026